Skip to main content
欧康医药 logo

欧康医药 — Investor Relations & Filings

Ticker · 920230 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 373 across all filing types
Latest filing 2026-03-29 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920230

About 欧康医药

https://www.okaypharm.com/

Oukang Pharmaceutical specializes in the research, development, and large-scale production of natural plant extracts, with a primary focus on citrus-derived flavonoids. The company’s core product portfolio includes high-purity ingredients such as Hesperidin, Diosmin, Methyl Hesperidin, and Neohesperidin Dihydrochalcone (NHDC). These products serve as essential raw materials for the global pharmaceutical, nutraceutical, food and beverage, and cosmetic sectors. Utilizing advanced extraction and purification technologies, the company maintains rigorous quality control standards to ensure compliance with international regulatory requirements. Its operations emphasize the industrialization of plant-based chemical derivatives to support diverse health and wellness applications.

Recent filings

Filing Released Lang Actions
关于公司获得原料药欧洲CEP证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a CEP certificate from the European Directorate for the Quality of Medicines (EDQM) for a pharmaceutical raw material. It details the certificate information, product description, impact on the company, and risk factors. The document is short (1096 characters) and serves as a formal announcement of a regulatory milestone rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a certification achievement that does not fit other specific categories.
2026-03-29 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of an invention patent certificate. It details the patent name, number, and its potential impact on the company, including cost reduction and environmental benefits. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is a regulatory announcement about intellectual property, not a financial report or management change. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-03-24 Chinese
第四届董事会第十五次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at the 15th meeting of the 4th Board of Directors of Chengdu Oukang Pharmaceutical Co., Ltd. It details the appointment of a new board secretary and a new financial officer, as well as the decision to dissolve a branch company. The document includes meeting attendance, voting results, and references to compliance with relevant laws and company articles. It does not contain financial statements or detailed financial performance data. The content focuses on board-level management changes and decisions. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 2201 characters, which is consistent with an announcement rather than a full report.
2026-03-09 Chinese
关于拟注销分公司的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Chengdu Oukang Pharmaceutical Co., Ltd. regarding the planned cancellation (注销) of a branch company. It includes details about the branch, reasons for cancellation, and confirms no adverse impact on the company or shareholders. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The document is a corporate announcement about a structural change (branch cancellation) approved by the board, not a financial report or regulatory filing. This fits best under a general regulatory announcement category. Given the content and length (975 characters), it is not a report publication announcement but a regulatory filing about corporate structural change. Therefore, the best classification is Regulatory Filings (RNS).
2026-03-09 Chinese
高级管理人员任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of senior management personnel, specifically the appointment of a board secretary and a financial officer. It includes details about the voting results, compliance with laws and regulations, and the qualifications of the appointed individuals. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2026-03-09 Chinese
2025年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2025 Annual Performance Express Announcement" and contains preliminary financial data for the year 2025, including revenue, profit, earnings per share, and asset information. It explicitly states that the data are preliminary and unaudited, with final audited data to be disclosed in the full 2025 Annual Report. The document is relatively short (1770 characters) and serves as a quick financial performance update rather than a comprehensive report. It includes a risk warning about the preliminary nature of the data and refers investors to the forthcoming annual report for detailed audited figures. This type of document is typically classified as an Earnings Release (ER), which provides initial key financial highlights for a fiscal year before the full annual report is published. FY 2025
2026-02-09 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.